Literature DB >> 8566063

Nerve growth-factor and anti-CD40 provide opposite signals for the production of IgE in interleukin-4-treated lymphocytes.

C Brodie1, A Oshiba, H Renz, K Bradley, E W Gelfand.   

Abstract

Nerve growth factor (NGF) is a well-known neurotrophic factor acting on both the peripheral and the central nervous systems. In addition, it has been shown to play a role in the function of the immune system through specific receptors. Both high-affinity and low-affinity NGF receptors (NGFR) are expressed on human B lymphocytes. The low-affinity NGFR has been shown to have structural homology with another specific B cell surface molecule, CD40, which plays an important role in IgE production. In view of the structural similarities of the p75 NGFR and CD40 we examined whether NGF may also be involved in the regulation of IgE production. We found that NGF and anti-CD40 exerted opposite effects on the induction of IgE by IL-4 in peripheral blood mononuclear cells. NGF inhibited the induction of IgE by IL-4 and this inhibition was not mediated through blocking of the induction of CD23 nor through inhibition of IL-4R expression. The inhibition of IL-4-dependent IgE production was observed on surface (s)IgE+ and sIgE-/sIgM+ B lymphocytes. Anti-CD40 on the other hand, exerted an enhancing effect on IgE production and its addition to IL-4 provided a signal that was resistant to the inhibitory effect of NGF. Antagonistic effects of NGF and IL-4 were also observed for other Ig isotypes since IL-4 prevented the increase in IgA and IgM production induced by NGF. These data indicate that although NGFR and CD40 belong to the same receptor superfamily and exert similar proliferative effects on B lymphocytes, they interact differently with IL-4 in the regulation of IgE production.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8566063     DOI: 10.1002/eji.1830260127

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  9 in total

Review 1.  Autonomic regulation of neuroimmunological responses: implications for multiple sclerosis.

Authors:  E M Frohman; N L Monson; A E Lovett-Racke; M K Racke
Journal:  J Clin Immunol       Date:  2001-03       Impact factor: 8.317

Review 2.  Neurotrophins and the immune system.

Authors:  José A Vega; Olivia García-Suárez; Jonas Hannestad; Marta Pérez-Pérez; Antonino Germanà
Journal:  J Anat       Date:  2003-07       Impact factor: 2.610

3.  Determination of serum interleukin-13 and nerve growth factor in patients with systemic lupus erythematosus and clinical significance.

Authors:  Zusen Xu; Yanlei Chen
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2005

Review 4.  Neurotrophins and B-cell malignancies.

Authors:  Jennifer Hillis; Michael O'Dwyer; Adrienne M Gorman
Journal:  Cell Mol Life Sci       Date:  2015-09-23       Impact factor: 9.261

5.  Disruption of antigen-induced airway inflammation and airway hyper-responsiveness in low affinity neurotrophin receptor p75 gene deficient mice.

Authors:  S Tokuoka; Y Takahashi; T Masuda; H Tanaka; S Furukawa; H Nagai
Journal:  Br J Pharmacol       Date:  2001-12       Impact factor: 8.739

Review 6.  A Microglial Function for the Nerve Growth Factor: Predictions of the Unpredictable.

Authors:  Alexia Tiberi; Simona Capsoni; Antonino Cattaneo
Journal:  Cells       Date:  2022-06-03       Impact factor: 7.666

7.  Low frequency of plasma nerve-growth factor detection is associated with death of memory B lymphocytes in HIV-1 infection.

Authors:  K Titanji; A Nilsson; C Mörch; A Samuelsson; A Sönnerborg; S Grutzmeier; M Zazzi; A De Milito
Journal:  Clin Exp Immunol       Date:  2003-05       Impact factor: 4.330

8.  A novel lymphocyte signaling defect: trk A mutation in the syndrome of congenital insensitivity to pain and anhidrosis (CIPA).

Authors:  I Melamed; J Levy; R Parvari; E W Gelfand
Journal:  J Clin Immunol       Date:  2004-07       Impact factor: 8.317

Review 9.  NGF and Its Receptors in the Regulation of Inflammatory Response.

Authors:  Gaetana Minnone; Fabrizio De Benedetti; Luisa Bracci-Laudiero
Journal:  Int J Mol Sci       Date:  2017-05-11       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.